Organogenesis Holdings, a regenerative medical company based in Canton, Massachusetts, specializes in advanced wound care and surgical products, employing 862 staff since its IPO on December 2, 2016. Their portfolio includes Apligraf, Dermagraft, and various placental allografts for treating wounds and soft tissue repairs.
Lori Freedman bought 142,379 shares of ORGO on 5 June at $2.91 per share, worth a total of $414K. They now own 837,437 ORGO shares, or a 20% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.